About 200 reports

  • BIOSIMILARS
  • DEFINING BIOSIMILARS
  • Biopharmaceutical
  • Biosimilar
  • World
  • Market Size
  • Remicade group
  • US Approved Biosimilars
  • 2.3 Overview of Biosimilars
  • Biosimilar
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • Biosimilars: Overview
  • Emergence of biosimilars
  • Biosimilar
  • Biocon Limited
  • Hospira, Inc.
  • Sandoz Inc.
  • Teva Pharmaceuticals Ltd.
  • BIOCON - MAJOR BIOSIMILARS IN PIPELINE
  • BIOSIMILARS MARKET - BY APPLICATIONS
  • Biosimilar
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • European Biosimilar Market - Immunomodulator -
  • Middle East & Africa Biosimilars Market - Immunomodulators -
  • Biosimilar
  • Biocon Limited
  • Hospira, Inc.
  • Mylan Inc.
  • Sandoz Inc.

##. ## What are Biosimilars?

  • Biopharmaceutical
  • Biosimilar
  • Europe
  • World
  • Market Size

##. ##. ## Biosimilar Infliximab: Currently the Second Largest Submarket ##. ##. ##. ## Biosimilar Infliximab Revenue Forecast 2016-2027 ##. ##. ## Biosimilar Rituximab: The Current Leading Submarket Driven by Sales in Russia ##. ##. ##. ## Biosimilar Rituximab: Revenue Forecast 2016-##

  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • World
  • Market Size

Biosimilars Market Snapshot Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025 Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025 Table ## Global Oncology Biosimilars Marke

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size

Global Biosimilars Industry I.

  • Biopharmaceutical
  • Biosimilar
  • Europe
  • United States
  • World

Global Biosimilar Market Outlook 2022 ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size

Reddy' s Laboratories - Hospira - Other prominent vendors PART ##: Appendix - List of abbreviations PART ##: Explore Technavio List of Exhibits Exhibit ##: Product offerings Exhibit ##: Global mAb biosimilars market: Snapshot Exhibit ##: Global mAb biosimilars market: Growth

  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • World
  • Market Size

Biosimilars Real World Evidence: Proving the point ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe

Biosimilars Market Access in the U. S. ## EXECUTIVE SUMMARY ## Regulatory pathway ## Substitution and naming ## Legal considerations ## Pricing, reimbursement, and access ## Education needs ## THE NEED FOR BIOSIMILARS ## What are biosimilars?

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • United States
  • Forecast

List Of Tables Table ## Global Insulin Biosimilars Market Outlook, By Region (2014-2023) ($MN) Table ## Global Insulin Biosimilars Market Outlook, By Biosimilars Type (2014-2023) ($MN) Table ## Global Insulin Biosimilars Market Outlook, By Rapid-Acting

  • Biopharmaceutical
  • Biosimilar
  • Asia
  • World
  • Forecast

Global Biosimilar Insulin Market Overview ##. ## Preface to Biosimilar Insulin Market ##. ## Biosimilar Competition Assessment ##.

  • Biosimilar
  • Insulin
  • Therapy
  • World
  • Market Size

Reddy' s Laboratories - F Hoffmann-La Roche - Hospira - Mylan - Sandoz - Other prominent vendors PART ##: Appendix - List of abbreviations PART ##: Explore Technavio List of Exhibits Exhibit ##: Product offerings Exhibit ##: Global biosimilars and oncology biosimilars mar

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size

Oncology - Bevacizumab Biosimilars Bevacizumab Biosimilar - Key Participants Bevacizumab Biosimilar - Revenue Forecast Bevacizumab Biosimilar - Adoption Rate and Patient Population Bevacizumab Biosimilar - Price and Discounts ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Market Size

This report analyzes the global markets for " Biosimilar Drugs".

  • Biosimilar
  • Asia
  • Europe
  • North America
  • World

Biosimilars: a quick snapshot of the current market ##. ## Strategic reasons for investing in the biosimilars market ##. ## Sizing the current biosimilars opportunity ##. ## The current commercial landscape for biosimilars ##. ## A summary of the current biosimilars

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug

Biosimilars: US Payer Perspectives ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug

Biosimilars in Europe: Where we currently stand ##. ## Biosimilar approvals in Europe to date ##. ## Uptake and usage of biosimilars in Europe ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe

Will your biosimilar face a price cap?

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • India

Biosimilar Market Outlook, By Region (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Product (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Peptides (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Erythropoietin (2013-2022) ($MN) ## Glob

  • Biosimilar
  • Asia
  • Europe
  • World
  • Forecast

Growth Opportunity and Market Forecast of Key Biosimilars—Rheumatoid Arthritis Growth Opportunity and Market Forecast of Key Biosimilars—Rheumatoid Arthritis Top-selling Biotech drugs Growth Opportunities in Rheumatoid Arthritis Etanercept Biosimilars—Adoption Rate Etanerc

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe
  • Forecast

Japan Biosimilars – A start of Authorized Biosimilar Era?

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Japan
  • COMPARISON OF BIOSIMILARS WITH BIOSIMILAR ANTIBODIES
  • DEVELOPMENT OF BIOSIMILARS
  • Biosimilar
  • Europe
  • World
  • Roche Group
  • Sandoz Inc.

Reddy’s Laboratories ##. ##. ## Darbepoetin Alpha Biosimilar – Cipla & Hetero Drugs Limited ##. ##. ## Darbepoetin Alpha Biosimilar – Hospira ##. ## Rituxan: Product Overview ##. ##. ## Rituximab Biosimilar – Sandoz ##. ##. ## Rituximab Biosimilar – Amgen ##. ##. ## Rituximab

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • China
  • Company

##. ## Key insights ##. ## How can biosimilar companies better educate key stakeholders about biosimilars?

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • United States
  • Market Size

Keep biosimilar adoption trending up.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe

Global Biosimilar Monoclonal Antibodies Market: Trend Analysis and Forecast to 2022 ##.

  • Biosimilar
  • Asia
  • Europe
  • World
  • Market Size